×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ICAD – icad inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ICAD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
02:04 am
icad
iCAD, Inc. (NASDAQ: ICAD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
iCAD, Inc. (NASDAQ: ICAD) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/19
07:02 pm
icad
iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript [Seeking Alpha]
High
Report
iCAD, Inc. (ICAD) Q4 2024 Earnings Call Transcript [Seeking Alpha]
3/19
04:08 pm
icad
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 [Yahoo! Finance]
High
Report
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024 [Yahoo! Finance]
3/19
04:01 pm
icad
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024
High
Report
iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024
3/18
11:03 pm
icad
iCAD, Inc. (NASDAQ: ICAD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
iCAD, Inc. (NASDAQ: ICAD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/11
08:00 am
icad
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
Medium
Report
iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
3/6
02:26 pm
icad
Global AI in Cancer Diagnostics Market to Observe Stunning Growth at a CAGR ~11% by 2032 | DelveInsight [Yahoo! Finance]
Medium
Report
Global AI in Cancer Diagnostics Market to Observe Stunning Growth at a CAGR ~11% by 2032 | DelveInsight [Yahoo! Finance]
3/5
02:04 pm
icad
iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America
Low
Report
iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/31
05:07 pm
icad
Form 10-K ICAD INC For: Dec 31
Medium
Report
Form 10-K ICAD INC For: Dec 31
2/27
09:56 pm
icad
Form 4 ICAD INC For: Feb 21 Filed by: Brown Dana R
Medium
Report
Form 4 ICAD INC For: Feb 21 Filed by: Brown Dana R
2/27
09:55 pm
icad
Form 4 ICAD INC For: Feb 21 Filed by: Lonnqvist Eric
Medium
Report
Form 4 ICAD INC For: Feb 21 Filed by: Lonnqvist Eric
2/7
04:07 pm
icad
Form 4 ICAD INC For: Feb 05 Filed by: Wood Susan Alyson
High
Report
Form 4 ICAD INC For: Feb 05 Filed by: Wood Susan Alyson
2/7
04:06 pm
icad
Form 4 ICAD INC For: Feb 05 Filed by: Hricak Hedvig
High
Report
Form 4 ICAD INC For: Feb 05 Filed by: Hricak Hedvig
2/7
04:06 pm
icad
Form 4 ICAD INC For: Feb 05 Filed by: Patel Rakesh
High
Report
Form 4 ICAD INC For: Feb 05 Filed by: Patel Rakesh
2/7
04:06 pm
icad
Form 4 ICAD INC For: Feb 05 Filed by: Doyle Michael John
High
Report
Form 4 ICAD INC For: Feb 05 Filed by: Doyle Michael John
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/23
iCAD Announces Pricing of $12.5 Million Registered Direct Offering
28.5%
2/27 Q4/2019 12/31/2019 EPS -0.100 ZacksConsensus -0.120 ActVsEst 0.020 - Beat 22.1%
2/13 iCAD to Report Fourth Quarter 2019 Financial Results on Thursday, February 27, 2020 12.0%
2/11 First Brain Tumor Treated with Xoft IORT in the United States 8.1%
7/10 SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence 7.5%
8/1 Q2/2019 6/30/2019 EPS -0.090 ZacksConsensus -0.100 ActVsEst 0.010 - Beat 7.2%
1/15 Form 3 ICAD INC For: Jan 13 Filed by: Klein Michael S 6.9%
9/10 iCAD’s ProFound AI Reader Study Published in Radiology: Artificial Intelligence 6.3%
6/13 iCAD Introduces ProFound AI™ for 2D Mammography in Europe 5.4%
4/28 iCAD Inc (NASDAQ: ICAD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.3%
2/27 Q4/2019 12/31/2019 EPS -0.100 ZacksConsensus -0.120 ActVsEst 0.020 - Beat 22.1%
2/13 iCAD to Report Fourth Quarter 2019 Financial Results on Thursday, February 27, 2020 12.0%
2/11 First Brain Tumor Treated with Xoft IORT in the United States 8.1%
7/10 SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence 7.5%
8/1 Q2/2019 6/30/2019 EPS -0.090 ZacksConsensus -0.100 ActVsEst 0.010 - Beat 7.2%
1/15 Form 3 ICAD INC For: Jan 13 Filed by: Klein Michael S 6.9%
9/10 iCAD’s ProFound AI Reader Study Published in Radiology: Artificial Intelligence 6.3%
6/13 iCAD Introduces ProFound AI™ for 2D Mammography in Europe 5.4%
4/28 iCAD Inc (NASDAQ: ICAD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 5.3%
TOP News Decliners
3/11
Form 10-K ICAD INC For: Dec 31
-17.2%
8/3 iCAD's (ICAD) CEO Michael Klein on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -11.3%
3/31 iCAD Announces New Credit Facility with Bridge Bank, Increasing Operational Flexibility -10.9%
7/11 iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval -9.3%
10/30 Q3/2019 9/30/2019 EPS -0.100 ZacksConsensus -0.100 ActVsEst 0.000 - In-Line -7.3%
5/15 Form 10-Q ICAD INC For: Mar 31 -5.9%
10/1 iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest -5.1%
10/1 iCAD Inc (NASDAQ: ICAD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -4.2%
3/23 iCAD Launches New Initiatives Leveraging Unique Capabilities of its Robust Product Portfolio to Reduce Health Care System Pressures During the COVID-19 Pandemic -4.0%
6/7 iCAD Inc (NASDAQ: ICAD) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -3.9%
8/3 iCAD's (ICAD) CEO Michael Klein on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -11.3%
3/31 iCAD Announces New Credit Facility with Bridge Bank, Increasing Operational Flexibility -10.9%
7/11 iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval -9.3%
10/30 Q3/2019 9/30/2019 EPS -0.100 ZacksConsensus -0.100 ActVsEst 0.000 - In-Line -7.3%
5/15 Form 10-Q ICAD INC For: Mar 31 -5.9%
10/1 iCAD Showcases ProFound AI™ Platform at European Society of Breast Imaging Annual Scientific Meeting in Budapest -5.1%
10/1 iCAD Inc (NASDAQ: ICAD) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -4.2%
3/23 iCAD Launches New Initiatives Leveraging Unique Capabilities of its Robust Product Portfolio to Reduce Health Care System Pressures During the COVID-19 Pandemic -4.0%
6/7 iCAD Inc (NASDAQ: ICAD) was upgraded by analysts at ValuEngine from a "buy" rating to a "strong-buy" rating. -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: